The World Health Organization (WHO) said it would look at whether the international drug patent system prevents developing countries from obtaining needed medicines, vaccines and diagnostic tests. The 192 WHO members agreed at an annual meeting in Geneva to launch an intergovernmental group to look for gaps in medical research and development, and draw up a global strategy to ensure the health needs of poor people are met. The report, commissioned by the WHO in 2003, did not call for a weakening of patent rights but urged big companies to reduce the price of medicines sold to developing countries and to avoid filing for patent protection there.
Patent Baristas
Simplifying Global Compliance
Recommended Products
EU MDR Compliance: A Checklist for Meeting Manufacturing, Safety and Performance Requirements
The FDAnews report EU MDR Compliance can help. Our editors have combed through the regulations, picking out the most minute compliance points and building them into a checklist of 200+ requirements you can use to confirm that you are satisfying all the EU mandates for device manufacturing.
Accelerating Generic Drug Development: The FDA’s New Plan for Increasing Generic Competition
Accelerating Generic Drug Development explains the FDA’s new policy and shows how to navigate the new pathway to approval.
Editor's Picks
BSI Warns Devicemakers to Migrate CE Certificates Before Brexit Deadline
BSI said that when it initiated its contingency plan in August 2016, it “could not have foreseen the lack of political progress” toward a Brexit resolution.
Democrats Introduce Price Gouging Bill
Brown and Gillibrand said the money from fines would be used for drug research and development.
FDAnews Device Daily Bulletin
WHO RELEASES REPORT PROMOTING INNOVATION RELEVANT TO DEVELOPING COUNTRIES
June 1, 2006
